Edmond DE Rothschild Holding S.A. Sells 467,004 Shares of Doximity, Inc. (NASDAQ:DOCS)

Edmond DE Rothschild Holding S.A. decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 45.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 555,165 shares of the company's stock after selling 467,004 shares during the quarter. Edmond DE Rothschild Holding S.A. owned about 0.30% of Doximity worth $29,640,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in DOCS. Global Retirement Partners LLC increased its stake in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC increased its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares during the period. Optimum Investment Advisors acquired a new stake in Doximity during the 4th quarter valued at approximately $43,000. Finally, Morse Asset Management Inc bought a new stake in shares of Doximity in the 3rd quarter worth about $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 37.40% of the stock is owned by insiders.

Doximity Price Performance

Shares of NASDAQ DOCS traded down $3.10 during trading hours on Friday, reaching $51.48. The stock had a trading volume of 1,363,490 shares, compared to its average volume of 1,944,749. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a market cap of $9.61 billion, a price-to-earnings ratio of 51.37, a PEG ratio of 4.10 and a beta of 1.34. The business's fifty day moving average is $65.60 and its two-hundred day moving average is $54.83.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on DOCS. KeyCorp lowered their price target on Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Wednesday, January 8th. Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Bank of America boosted their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their target price for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Finally, Stephens started coverage on Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target on the stock. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.